Free Trial

7,564 Shares in MetLife, Inc. $MET Purchased by Hilltop National Bank

MetLife logo with Finance background

Key Points

  • Hilltop National Bank acquired 7,564 shares of MetLife, Inc., valued at approximately $608,000, in the second quarter, reflecting continued institutional interest in the company.
  • Shares of MetLife have seen a one-year high of $89.05 and a low of $65.21, with the stock currently opening at $82.41, indicating a relatively stable performance within that range.
  • Equity analysts have mixed views on MetLife, with the consensus rating being a Moderate Buy and a price target average of $94.64, suggesting potential upside in the stock.
  • Five stocks to consider instead of MetLife.

Hilltop National Bank acquired a new position in shares of MetLife, Inc. (NYSE:MET - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 7,564 shares of the financial services provider's stock, valued at approximately $608,000.

Several other institutional investors have also recently modified their holdings of MET. Diamond Hill Capital Management Inc. acquired a new position in shares of MetLife during the 1st quarter worth approximately $336,965,000. Nuveen LLC acquired a new position in shares of MetLife during the 1st quarter worth approximately $312,946,000. Price T Rowe Associates Inc. MD raised its position in shares of MetLife by 7.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,488,146 shares of the financial services provider's stock worth $2,126,734,000 after purchasing an additional 1,824,907 shares during the last quarter. Alyeska Investment Group L.P. acquired a new position in shares of MetLife during the 1st quarter worth approximately $68,030,000. Finally, AQR Capital Management LLC lifted its stake in shares of MetLife by 85.0% during the first quarter. AQR Capital Management LLC now owns 1,321,881 shares of the financial services provider's stock valued at $104,270,000 after buying an additional 607,333 shares during the period. 94.99% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts recently issued reports on MET shares. Wolfe Research raised shares of MetLife to a "strong-buy" rating in a research note on Tuesday, September 16th. Cowen reissued a "buy" rating on shares of MetLife in a research note on Friday, August 22nd. Keefe, Bruyette & Woods reduced their price objective on shares of MetLife from $94.00 to $92.00 and set an "outperform" rating on the stock in a research note on Monday, August 11th. Wells Fargo & Company reissued an "overweight" rating and set a $97.00 price objective (up previously from $94.00) on shares of MetLife in a research note on Thursday, July 10th. Finally, UBS Group reduced their price objective on shares of MetLife from $94.00 to $91.00 and set a "buy" rating on the stock in a research note on Thursday, August 7th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, MetLife has a consensus rating of "Moderate Buy" and a consensus price target of $94.64.

Check Out Our Latest Report on MetLife

MetLife Stock Performance

Shares of MET stock opened at $82.41 on Friday. MetLife, Inc. has a one year low of $65.21 and a one year high of $89.05. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.16 and a current ratio of 0.16. The company has a 50 day moving average price of $79.10 and a 200 day moving average price of $78.20. The firm has a market capitalization of $54.81 billion, a price-to-earnings ratio of 13.97, a price-to-earnings-growth ratio of 0.73 and a beta of 0.86.

MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing the consensus estimate of $2.32 by ($0.30). MetLife had a return on equity of 19.88% and a net margin of 5.83%.The company had revenue of $17.34 billion for the quarter, compared to analyst estimates of $18.58 billion. During the same period last year, the company posted $2.28 EPS. The business's revenue for the quarter was down 2.7% on a year-over-year basis. Sell-side analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 9th. Stockholders of record on Tuesday, August 5th were given a $0.5675 dividend. The ex-dividend date of this dividend was Tuesday, August 5th. This represents a $2.27 annualized dividend and a dividend yield of 2.8%. MetLife's dividend payout ratio is presently 38.47%.

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Articles

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.